Acceptability and Usability of the Family Gene Toolkit for Swiss and Korean Families Harboring BRCA1/BRAC2 Pathogenic Variants: A Web-Based Platform for Cascade Genetic Testing

Author:

Baroutsou Vasiliki1ORCID,Duong Vu1,Signorini Alice1,Saccilotto Ramon1,Ciorba Florina M.2,Bürki Nicole3,Caiata-Zufferey Maria4ORCID,Ryu Jai Min5,Kim Sung-Won6,Lim Myong Cheol7ORCID,Monnerat Christian8,Zürrer-Härdi Ursina9,Kim Jisun10ORCID,Heinimann Karl1112,Graffeo Rossella13ORCID,Park Ji Soo14,Rabaglio Manuela15ORCID,Chappuis Pierre Olivier1617ORCID,Kim Sue18ORCID,Katapodi Maria C.1ORCID,

Affiliation:

1. Department of Clinical Research, Faculty of Medicine, University of Basel, 4055 Basel, Switzerland

2. Department of Mathematics and Computer Science, University of Basel, 4051 Basel, Switzerland

3. Women’s Clinic, University Hospital Basel, 4031 Basel, Switzerland

4. Department of Business Economics, Health and Social Care, University of Applied Sciences and Arts of Southern Switzerland, 6928 Manno, Switzerland

5. Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea

6. Department of Breast Surgery, Breast Care Center, Dairim St Mary’s Hospital, Seoul 07442, Republic of Korea

7. Division of Tumor Immunology, Center for Gynecologic Cancer Research Institute and Hospital, National Cancer Center, Goyang 10408, Republic of Korea

8. Department of Medical Oncology, Hospital of Jura, 2800 Delemont, Switzerland

9. Department of Medical Oncology, Cantonal Hospital Winterthur, 8400 Winterthur, Switzerland

10. Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea

11. Institute for Medical Genetics and Pathology, University Hospital Basel, 4031 Basel, Switzerland

12. Research Group Human Genomics, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland

13. Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), 6500 Bellinzona, Switzerland

14. Hereditary Cancer Clinic, Cancer Prevention Center, Yonsei Cancer Center, Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03772, Republic of Korea

15. Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland

16. Unit of Oncogenetics, Division of Precision Oncology, University Hospitals of Geneva, 1205 Geneva, Switzerland

17. Division of Genetic Medicine, University Hospitals of Geneva, 1205 Geneva, Switzerland

18. College of Nursing, Yonsei University, Seoul 03722, Republic of Korea

Abstract

The study adapted the Family Gene Toolkit and developed a customized web application for Swiss and Korean families harboring BRCA1 or BRCA2 pathogenic variants to support family communication of genetic testing results and promote cascade genetic testing among at-risk relatives. In the first step, narrative data from 68 women with BRCA1/BRCA2 pathogenic variants and clinician feedback informed a culturally sensitive adaptation of the content consistent with current risk management guidelines. In the second step, the Information Technology team developed the functions and the interface of the web application that will host the intervention. In the third step, a new sample of 18 women from families harboring BRCA1/BRCA2 pathogenic variants tested the acceptability and usability of the intervention using “think-aloud” interviews and a questionnaire. Participants expressed high levels of satisfaction with the intervention. They provided positive feedback for the information regarding active coping, strategies to enhance family communication, interactive elements, and illustrative stories. They reported that the information was useful and the web application was easy to navigate. Findings suggest that the Family Gene Toolkit is well-designed and can increase rates of cascade testing among at-risk relatives. Its efficacy will be tested in a subsequent randomized trial.

Funder

Swiss Cancer League

Swiss Cancer Research Foundation

Swiss National Science Foundation

National Research Foundation of Korea

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference68 articles.

1. Hereditary Cancer Syndromes-A Primer on Diagnosis and Management: Part 1: Breast-Ovarian Cancer Syndromes;Samadder;Mayo Clin. Proc.,2019

2. (2023, April 19). Prevention Centers for Disease Control and Cascade Testing for Hereditary Breast and Ovarian Cancer, Available online: https://www.cdc.gov/genomics/disease/cascade_testing/cascade_hboc.htm.

3. A Population-Based Study of Genes Previously Implicated in Breast Cancer;Hu;N. Engl. J. Med.,2021

4. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 3.2023: Updates to the NCCN Guidelines;Daly;J. Natl. Compr. Cancer Netw.,2023

5. What guidance does HIPAA offer to providers considering familial risk notification and cascade genetic testing?;Henrikson;J. Law Biosci.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3